What is the management of Rhabdomyolysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Rhabdomyolysis

The cornerstone of rhabdomyolysis management is aggressive intravenous fluid resuscitation, with volumes greater than 6L required for severe cases (CK >15,000 IU/L) and 3-6L per day for moderate cases, initiated as early as possible to prevent acute kidney injury. 1, 2

Diagnosis and Assessment

  • Rhabdomyolysis is diagnosed when creatine kinase (CK) levels exceed five times the upper limit of normal (approximately 1000 IU/L), with myoglobin having an earlier peak plasma concentration making it more sensitive for early detection 2
  • Clinical presentation ranges from asymptomatic enzyme elevations to life-threatening complications including acute kidney injury, severe electrolyte abnormalities, compartment syndrome, and disseminated intravascular coagulation 3
  • Laboratory assessment should include:
    • Plasma myoglobin and CK measurements 1
    • Complete electrolyte panel (particularly potassium, calcium, phosphorus, and magnesium) 1
    • Renal function tests 1
    • Liver function tests 1
    • Coagulation studies to evaluate for disseminated intravascular coagulation 1
    • Arterial blood gas analysis to assess for metabolic acidosis 1

Treatment Algorithm

Immediate Management

  • Begin aggressive IV fluid resuscitation immediately 1, 4:
    • For severe rhabdomyolysis (CK >15,000 IU/L): >6L of fluid per day
    • For moderate cases: 3-6L per day
    • Target urine output of 300 mL/hour 3, 5
  • Monitor and correct significant electrolyte abnormalities, particularly hyperkalemia which can lead to cardiac arrhythmias 1, 6
  • For patients with myoglobin >600 ng/mL, maintain urine pH at 6.5 2

Monitoring

  • Perform repeated bioassessment including plasma myoglobin, CK, and electrolytes 1
  • Monitor urine output hourly 2
  • Assess for compartment syndrome, with early signs including pain, tension, paresthesia, and paresis 1, 6
  • Late signs of compartment syndrome include pulselessness and pallor, which often indicate irreversible damage 1

Compartment Syndrome Management

  • Consider fasciotomy when compartment pressure exceeds 30 mmHg or when differential pressure (diastolic blood pressure – compartment pressure) is <30 mmHg 1, 6
  • Early fasciotomy is indicated for established compartment syndrome 1

Cause-Specific Management

  • Identify and address underlying causes of rhabdomyolysis, which may include 7, 3:
    • Trauma or direct injury
    • Excessive muscle activity
    • Hereditary muscle enzyme defects
    • Drugs and toxins (particularly statins)
    • Muscle hypoxia
    • Metabolic and endocrine disorders
    • Infections
    • Temperature alterations
  • For statin-associated rhabdomyolysis, discontinue statin therapy immediately 6
  • For immune checkpoint inhibitor-induced myositis with rash, consider high-dose corticosteroids 6
  • For infectious causes, administer appropriate antimicrobial therapy based on suspected pathogen 6

Prevention of Complications

  • Early fluid resuscitation is critical, as delayed treatment is associated with higher risk of acute kidney injury 1, 4
  • In crush syndrome, CK levels above 75,000 IU/L correlate with a high incidence (>80%) of acute kidney injury 2
  • Avoid medications that can exacerbate rhabdomyolysis, particularly succinylcholine 1
  • Consider renal replacement therapy for severe cases with significant renal impairment 6

Special Considerations

  • For exertional rhabdomyolysis, proper calibration of training and conditioning is recommended, especially during transition periods 1, 6
  • Maintain adequate hydration throughout the perioperative period for surgical patients 1
  • For perioperative patients, consider discontinuation of dietary supplements associated with theoretical or known higher risk for myositis or rhabdomyolysis 8

References

Guideline

Rhabdomyolysis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Serum Myoglobin Levels and Rhabdomyolysis Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Early fluid resuscitation in patients with rhabdomyolysis.

Nature reviews. Nephrology, 2011

Guideline

Rhabdomyolysis with Rash Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The other medical causes of rhabdomyolysis.

The American journal of the medical sciences, 2003

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.